Immune and Safety Analysis of <i>ultra</i>IPV<sup>TM</sup>, a Novel UVC-Inactivated Polio Vaccine
The eradication of poliovirus remains a global health priority, with inactivated polio vaccines (IPVs) playing a pivotal role in immunization strategies. Over the past decades, advancements in IPV production have focused on optimizing safety, efficacy, and immunogenicity while addressing vaccine pro...
Saved in:
Main Authors: | David A. MacLeod, John K. Tobin, Ruth V. Bushnell, Taralyn J. Wiggins, Shyamkumar TS, Ramchander Nadipelly, Steven Lawson, Viju V. Pillai, Gregory J. Tobin, Stephen J. Dollery |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2025-06-01
|
Series: | Viruses |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4915/17/7/915 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Promising opportunities to improve polio vaccines
by: E. E. Evreinova, et al.
Published: (2022-07-01) -
Preventive Vaccination against Poliomyelitis: Modern View
by: E. V. Karpova, et al.
Published: (2018-12-01) -
Acute Transverse Myelitis in a Child Following Oral Live Polio Vaccine Administration
by: Kramarov S, et al.
Published: (2025-07-01) -
Modeling undetected poliovirus circulation following the 2022 outbreak in the United States
by: Dominika A. Kalkowska, et al.
Published: (2024-12-01) -
Communicable Episode 18: The Nightmare Series, part 4 – rubella & polio
by: Kathryn Hostettler, et al.
Published: (2025-06-01)